Menu
Not yet recruiting NCT06044129

A Novel Approach Integrating Magnetic Resonance Imaging (MRI) Data and Artificial Intelligence for Predicting the Success Rate of Vaginal Delivery in Pregnant Women

— Observational Vaginal Delivery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Mri scan of fetal head and pelvis.
Who it may be relevant to
Registry conditions: Vaginal Delivery. Basic parameters: 18 years — 35 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The aim of this study was to use MRI imaging to accurately scan the pregnant woman's pelvis and fetal skull, build a 3D model of them, and combine with artificial intelligence to develop an accurate tool to predict the success rate of vaginal delivery.

Interventions

  • Device Mri scan of fetal head and pelvis
    The pelvic parameters and fetal head parameters of pregnant women were measured by MRI, including pelvic entrance plane, middle pelvic plane, pelvic outlet plane, pubic arch Angle, double parietal diameter, occipitofrontal diameter, and suboccipital fontanel diameter.

Primary outcome measures

  • The mode of delivery [Time frame: during delivery]

Eligibility criteria

Inclusion criteria

  • Full-term.
  • Single fetus, head first.
  • Pregnant women have vaginal couvade wishes.
  • Complete clinical data of pregnant women.

Exclusion criteria

  • Pregnancy with serious medical and surgical diseases.
  • Abnormal fetal position (such as transverse, breech, etc.).
  • Twin or multiple pregnancies.
  • Vaginal couvade contraindications such as placenta previa.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University — Wenzhou

Identifiers

NCT: NCT06044129 · SAHoWMU-CR2023-07-209

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗